Hospital Universitario Araba

Vitoria-Gasteiz 01010

0 studies enrolling now · 6 studies all time

What they study most

DLBCL Transformed From Indolent Lymphoma, Deep Vein Thrombosis, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, Idiopathic Hypersomnia, Insomnia, Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53, Systemic Lupus Erythematosus, Venous Thromboembolism, de Novo DLBCL

Studies at this site

• A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus — Completed
• Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder — Completed
• p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246 — Completed
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study — Completed
• A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension — Completed
• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant — Completed